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Abstract.  The accompanying report (Watanabe, M., 
A.  L. Frelinger III, and U.  Rutishauser,  1986, J.  Cell 
Biol.,  103:1721-1727) describes a  set of monoclonal an- 
tibodies (mAbs) directed against N-CAM epitopes 
representing the known major structural and functional 
domains of the molecule. In this study, we have gener- 
ated and separated a  variety of peptide frag- 
ments from N-CAM,  and then used their size and re- 
activity with each antibody to position the antigenic 
sites along the peptide chain. This epitope map, to- 
gether with the biological properties of the antibodies 
and previous studies on N-CAM,  have been used to 
construct a  topographical model for the molecule in 
the cell membrane. 
p 
REVIOUS studies on the  structure of the neural cell 
adhesion molecule (N-CAM) l  (23)  have led to the 
proposal that the overall structure of the molecule is 
a single polypeptide chain divided into three regions (3): an 
amino-terminal 65-kD domain that includes the homophilic 
cell-cell binding site (24),  a central region containing the 
large and unusual polysialic acid (PSA) moieties (5, 15), and 
a membrane-associated region extending to the carboxyl ter- 
minus (3). Further analyses demonstrated that the molecule 
spans the cell membrane and is synthesized in three predomi- 
nant polypeptide forms (15, 22) that differ in the size of their 
cytoplasmic extension (9). The N-CAM gene has been iden- 
tified in both mouse (12) and chicken (20), and a partial se- 
quence of the chicken gene has been reported (13). 
Although a full understanding of N-CAM synthesis, ex- 
pression, and structure will require a detailed chemical anal- 
ysis of the molecule and its gene,  the description of the 
molecule's structure-function relationships depends on the 
use  of additional  approaches.  Since  the  advent  of mAb 
methods, it has become clear that the characterization and 
localization of individual antigenic sites can be a powerful 
method for obtaining information about both the linear and 
conformational features of large polypeptides.  Moreover, 
these mAbs can then be used as highly specific probes for 
the different activities and structural variants that occur in 
the animal. Examples of proteins that have been studied by 
this approach are fibronectin (8), the acetylcholine receptor 
(18), fodrin (11), and myosin (7,  17). 
Other investigators have used mAbs to verify that N-CAM 
has  a  cytoplasmic domain (9),  to  demonstrate cell type- 
specific variants in N-CAM-associated antigens (28), and to 
establish that the molecule has a heparin-binding region (1). 
1. Abbreviations used in this paper: Endo-F, endoneuraminidase F; N-CAM, 
neural cell adhesion molecule; PSA, polysialic acid. 
The present study is based on a diverse set of mAbs whose 
biological activity and epitopes have been characterized ex- 
tensively in the preceding paper (27). This paper focuses on 
the placement of these epitopes in the linear sequence of the 
polypeptide chain, and the construction of a detailed model 
for N-CAM that takes into account the known structural and 
functional features of the molecule. 
Materials and Methods 
Except  for  the  procedures  described  below,  all  reagents,  mAbs,  and 
methods,  including  preparation  of the  65-kD  amino-terminal  fragment 
(Frl), were as described in the accompanying paper (27). 
Preparation of  N-CAM-160 
The 160-kD N-CAM polypeptide, the largest of the three major N-CAM 
proteins, was immunoaffinity-purified from 14-d chick embryo brain by es- 
tablished procedures (15) using mAb 4I). As previously reported (27), this 
antibody reacts with the 160-kD form of N-CAM but not with the 130- or 
ll0-kD  forms,  suggesting that  it recognizes an epitope in the carboxyl- 
terminal 30-kD portion of N-CAM-160. The majority of the N-CAM puri- 
fied was glycosylated N-CAM-160 (molecular mass range, 200-230 kD; 16) 
with  some  smaller  fragments  presumably  derived  from  the  carboxyl- 
terminal portion of the molecule. 
Cleavage of  Frl and N-CAM-160 
To improve the reproducibility of cleavage patterns obtained with enzymes, 
N-CAM-160 or Frl (2 mg/ml) were first denatured by boiling for 3 min in 
the presence of 0.5 % SDS (for V-8 protease) or NP-40 (trypsin). Polypep- 
tide fragments were generated by treatment with V-8 protease (1:150, 1:750, 
or 1:3750 wt/wt enzyme/N-CAM for 30 min at 37°C; Sigma Chemical Co., 
St. Louis, MO), trypsin (1:300, 1:1500, or 1:7500 wt/wt for 30 min at 37°C; 
Sigma Chemical Co.), or cleavage with saturated cyanogen bromide (CNBr) 
in 70% formic acid for 2 h at room temperature followed by lyophilization. 
The digests were separated by SDS PAGE,  and immunoblotted with each 
antibody. 
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To position mAb  epitopes along  the N-CAM  polypeptide 
chain, we tested each mAb for its ability to recognize differ- 
ent  subpopulations of proteolytic and  CNBr  fragments of 
N-CAM and Frl. Assignment of epitope position was based 
on the following: groups of antibodies that recognized the 
same set of larger fragments, the use of epitopes present in 
more than one set to order these peptides, and then a final 
adjustment of relative locations according to antibody stain- 
ing of a variety of smaller fragments. All tests for antibody 
reactivity were carried out by immunoblotting methods after 
the fragments were separated by SDS PAGE. The mAbs were 
initially screened for reaction with N-CAM that had been 
boiled  in  SDS  (27),  and  all  also  recognized epitopes  as- 
sociated with the fractionated peptides. 
The use of SDS PAGE to separate the fragments has also 
provided an estimate of polypeptide chain length, which is 
an important parameter in the construction of the epitope 
map. The presence of carbohydrate on a fragment, although 
in many cases representing a useful epitope, introduces error 
into the assignment of polypeptide length. To assess the mag- 
nitude of this uncertainty, the enzyme endoneuraminidase F 
(endo-F)  (27)  was  used  to  remove  all  N-linked  carbohy- 
drate from several of the fragments (because of their rarity 
and small size, it is assumed that O-linked oligosaccharides 
have little if any impact on the estimation of N-CAM peptide 
size). With the exception of the PSA-containing fragment, 
which has been considered separately in the accompanying 
paper (27), fragments that had originally been recognized by 
antibodies directed against carbohydrate decreased in appar- 
ent molecular mass by ~3 kD after treatment with endo-E 
Fragments reacting with two of these mAbs decreased in size 
by 6 kD (data not shown). In the following epitope analysis, 
fragments have not been routinely treated with endo-F to re- 
tain  information  about  the  distribution  of  carbohydrate- 
dependent antigens.  Instead,  on the basis of the consistent 
effect obtained with endo-E the apparent length of the frag- 
ment polypeptides has been decreased by 0, 3, or 6 kD, ac- 
cording  to  the  number  of different carbohydrate epitopes 
detected. 
The information and logic used to construct an epitope 
map from a  large  number of fragments and  antibodies  is 
difficult to present directly from the immunoblots of frac- 
tionated peptides. Therefore, presentation of the results will 
begin  with  the  SDS  PAGE  and  immunoblot  information, 
progress to a tabular summary of the most important frag- 
ments, and then conclude with alignment of only those pep- 
tides that are essential to the placement of epitopes. For sim- 
plicity, the results will be presented separately for peptides 
generated  from  the  65-kD  amino-terminal  Frl  fragment 
of N-CAM,  and  then  for peptides  generated  from  intact 
N-CAM-160, which is the largest of the naturally occurring 
N-CAM polypeptides. 
Recognition by mAbs of  Fragments 
Generated from Frl 
The 65-kD Frl fragment of N-CAM, which has been shown 
to contain the N-CAM amino terminus (3), was shown in the 
accompanying paper to react with mAbs 10A, liB, 9A, 12B, 
PP, 79B, 5E, 104, and CHO, but not 105, 30B, or 4D. When 
this  65-kD  fragment  was  treated  with  endo-F  to  remove 
N-linked carbohydrate, reactivity with  104 and  CHO,  but 
not other mAbs, was eliminated and the apparent molecular 
mass decreased by '~6-59 kD.  This is consistent with the 
previous finding that mAbs 104 and CHO are carbohydrate- 
dependent (27), and that only a small portion of  total N-CAM 
glycosylation is associated with this fragment (3). 
The trypsin and V-8 protease fragments of the glycosylated 
(65-kD) form were separated by electrophoresis, transferred 
to nitrocellulose, and then reacted with each mAb. Staining 
of these fragments with the different mAbs revealed three 
distinct patterns of reactivity (Fig.  1), with a few important 
variations (Figs.  2 and 3).  In Fig.  1, A represents staining 
with mAb 12B and also exemplifies the pattern obtained with 
10A, 9A,  liB,  and  PP.  The similarity of these patterns  is 
demonstrated by a comparison of A with B, which was pro- 
duced by reaction with liB. In contrast, mAbs 79B and 5E 
both stained a  very different group of fragments (C),  and 
fragments recognized by CHO and 104 represented the third 
major pattern (D). 
Similarities and differences in the staining of selected frag- 
ments of Frl are summarized in Table I. Peptides recognized 
by the same subset of mAbs are grouped together: group I 
(Fig.  1,  A-D)  includes  large  fragments that  reacted with 
many mAbs, group II fragments (Fig. 1 C) reacted only with 
5E and 79B, group III (Fig.  1, A and B) represents peptides 
Figure 1.  mAb immunoblots of peptides generated from Frl and 
separated by SDS PAGE. Apparent molecular masses are indicated 
in kilodaltons, and three digest conditions with V-8 protease (Va, 
Vb,  Vc) and trypsin  (Ta, Tb,  Tc) are  shown (see Materials and 
Methods). (A) Basic pattern obtained with mAbs 12B, 10A, liB, 
9A, and PP. Actual blot shown is for 12B. The reproducibility of 
the  blots is  indicated by  comparison  of A  with B,  the  latter 
representing antibody liB. (C) Peptides stained by either antibodies 
5E (shown) or 79B. (D) Basic pattern produced with antibodies 
CHO (shown) and 104. Two relatively subtle variations from these 
basic groups are illustrated in Figs. 2 and 3. 
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of Fr  l 
mAb 
Group  Peptide  5E  79B  PP  12B  9A  liB  10A  104  CHO 
I  Frl-59(65)  +  +  +  +  +  +  +  +  + 
T49(55)  +  +  +  +  +  +  +  +  + 
T47(50)  +  +  +  +  +  +  +  + 
T41(44)  +  +  +  +  +  +  +  + 
II  V40  +  + 
V38  +  + 
V36  +  + 
T25  +  + 
V22  +  + 
III  T34(37)  +  +  +  +  +  + 
T23  +  +  +  +  + 
IV  T27  +  +  + 
T18  +  +  + 
Data derived from  Figs. 1-3. The peptide names indicate  the enzymes  used for 
cleavage (T, trypsin; V, V-8 protease) followed  by the estimated polypeptide 
size in kilodaltons and, where applicable, the size of the glycosylated  peptide 
in parenthesis. Antibodies 105, 30B, and 4D did not recognize  any peptides de- 
rived from Frl. 
Figure 2. Differences  in the trypsin fragments  recognized by anti- 
bodies CHO and  104, as revealed  by longer autoradiographic  ex- 
posure  of the  immunoblots  represented  in  Fig.  1 D.  Note that 
several large peptides  >Mr 55 kD are recognized by both antibod- 
ies, but that smaller fragments at 50, 44, and 37 kD are only stained 
by 104. 
stained by many mAbs but not by 5E and 79B, and group IV 
consists of two fragments that share the 5E, 79B, and PP epi- 
topes (Fig. 3). Further analysis of  these fragments for the 104 
and  CHO  epitopes  (Fig.  2)  revealed  that  two  of the  four 
group I  fragments did not react with CHO, and one of the 
group III peptides  did not react with  104 or CHO. 
Figure 3. Tryptic peptides rec- 
ognized in common by anti- 
bodies  5E and  PP.  Although 
the overall pattern of peptides 
recognized by 5E (and 79B) is 
distinct  from  that  obtained 
with  PP  (see  Fig.  1),  some 
tryptic peptides  (44,  27,  and 
18  kD,  arrows)  contain  all 
three  epitopes.  The  smaller 
two can be distinguished  from 
the larger in that they are also 
not  recognized  by  12B, 9A, 
liB,  10A, and  104  (Fig.  1). 
These  results  are  essentially 
the same as shown under Tc in 
Fig.  1, A and C, except that the 
similarities  are emphasized by 
better  gel  resolution,  longer 
autoradiographic exposure, and 
juxtaposition  of the  two  pat- 
terns. 
Epitopes on Fragments of N-CAM-160 
The patterns  of mAb staining obtained with fragments de- 
rived  from N-CAM-160 are  shown  in  Fig.  4.  mAbs  that 
recognize  similar  fragments  are  represented  by  a  single 
panel.  As would be expected, epitopes representing the Frl 
region (5E, 79B, PP,  12B, 9A,  llB,  10A, and CHO;  104 was 
not tested) are again represented by three major patterns with 
minor variations.  However, these patterns, while reproduci- 
ble (compare 5E with 79B, and PP with 12B) are quite differ- 
ent from the corresponding patterns  derived from Frl.  Al- 
though the differences are in part due to a slight increase in 
acrylamide concentration, the major factor seems to be that 
N-CAM-160 is more rapidly degraded than Frl.  In the case 
of CHO, additional  fragments are detected in the CNBr di- 
gest of  N-CAM-160 that are also recognized by mAbs against 
epitopes not contained within Frl. Thus, unlike the polypep- 
tide-dependent  Frl  epitopes,  the  carbohydrate-dependent 
CHO antigen appears to be repeated in other regions. In fact, 
as demonstrated in the final map,  this  epitope occurs at at 
least  three positions along the N-CAM polypeptide chain. 
Since  the  NH2-terminal  region  of N-CAM  has  already 
been characterized with peptides derived from Frl, the frag- 
ments obtained from N-CAM-160 are primarily considered 
with respect to the central and carboxyl-terminal portions of 
the polypeptide. These regions are recognized by mAbs 105, 
30B,  4D,  CHO,  and 20A (another  carbohydrate-dependent 
antigen  distinct  from the CHO epitope).  Whereas  staining 
with CHO,  105, and 4D each gave a  distinct  fragment pat- 
tern,  20A and 30B produced very similar patterns  (Fig. 4). 
However, 20A and 30B differ in that 20A recognizes all forms 
of N-CAM (data not shown) and the 30B epitope is confined 
to N-CAM-160 (27). 
When the N-CAM-160 fragments were arranged accord- 
ing to the presence of epitopes (Table II), eight groups could 
be distinguished.  The first two sets correspond to groups I 
and II from digests of Frl (Table I). The third group provides 
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of  peptides  generated  from 
N-CAM-160 and separated by 
SDS  PAGE. Different  digest 
conditions are shown for V-8 
protease (Va, Vb), trypsin (Ta, 
Tb) and CNBr,  and the anti- 
body represented by each blot 
is indicated. The blots for 9A, 
12B, liB, and 10A were iden- 
tical  to  each  other  (12B  is 
shown), as well as to PP. 
additional information about the Frl region in that it is a frag- 
ment containing the 5E but not the 79B epitope. Group IV, 
V, and VI peptides contain part of the central, carbohydrate- 
rich region of the polypeptide as identified by the  105 epi- 
tope, which has been shown (27) to be associated with the 
36-kD PSA-containing CNBr fragment (14). The differences 
between groups IV, V, and VI allow discrimination of epi- 
topes  105  and  CHO  from 20A,  30B,  and  4D.  Moreover, 
group  V  also  reacts  with  mAbs  30B  and  4D,  which  are 
specific for the intracellular domain of N-CAM-160. Group 
VII is recognized only by 20A and 30B and, together with 
the  4D-specific  group  VIII,  serves  to  distinguish  among 
these epitopes. 
Construction of  a Linear Map of  Epitopes 
The groups of peptides recognized by subsets of antibodies 
as presented in Tables I and II indicate that certain epitopes 
are  closely linked  to  others.  To place  individual  epitopes 
along the polypeptide chain, it remains to order these linkage 
groups,  establish  the  sequence  of  the  epitopes  within  a 
group, and, finally, to position them according to the size of 
overlapping fragments. The fragments characterized in Figs. 
1-4 account for all of the epitopes described in the accom- 
panying paper  (27),  and  provide sufficient information to 
place them with considerable resolution along the polypep- 
tide  chain.  The  rationale behind  this  map, based on  rep- 
resentative fragments from each group in Tables I and II, to- 
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mAb 
Group  Peptide  5E  79B  PP  12B  9A  11B  10A  105  CHO  20A  30B  4D 
I  V43  +  +  +  +  +  +  + 
II  V36  +  + 
V35  +  + 
V34  +  + 
C32  +  + 
C28  +  + 
T27  +  + 
V21  +  + 
III  V23 
IV  C36(65-130) 
V  C31 (37) 
C26(32) 
C25(31) 
VI  V25 
VII  V26(29) 
V16(19) 
VIII  T21 
T19 
+ 
+  + 
+  +  +  +  + 
-t-  +  +  +  + 
+  +  +  +  + 
+ 
+  + 
+  + 
+ 
+ 
Data derived from Fig. 4. The peptide names indicate the method used for cleavage (T, trypsin; V, V-8 protease; C, cyanogen bromide) followed by the estimated 
polypeptide size in kilodaltons and,  where applicable,  the size of the glycosylated peptide in parenthesis. 
gether with their estimated polypeptide lengths from Figs. 
1-4, is displayed in Fig. 5 and described below. The nomen- 
clature  used  for fragments  is  described in  the  legend of 
Table II. 
The amino-terminal 59-kD portion of the molecule is rep- 
resented by fragment Frl and epitopes 5E, 79B, PP, 12B, 9A, 
liB, 10A, 104, and CHO. The key fragments in establishing 
the overall structure within this region are the  three Frl- 
derived peptides V40,  T34(37), and T18. V40 only contains 
epitopes 5E and 79B; T34(37) contains all Frl epitopes ex- 
cept 5E, 79B and CHO; while T18 (and also T27) reacted 
with PP as well as with 5E and 79B, and therefore provides 
both a link between V40 and T34(37) and places PP at one 
end of I34(37). Additional resolution in the placement of Frl 
determinants is achieved through peptides V23 and T41 (44). 
V23 contains only 5E and because of its large size relative 
to T18, places this epitope on the amino terminal side of 79B. 
T41(44) has all Frl epitopes except CHO, and therefore re- 
stricts this epitope to one end of Frl. In fact, the size and po- 
sition of the other CHO-minus peptides described above in- 
dicate that  this  epitope lies  within  a  short distance  from 
either the amino or carboxyl terminus of Frl. Because the 
Frl fragment staining pattern obtained for CHO was identi- 
cal to that for 104 (Fig. 1) except for the absence of T47(50) 
and T41(44)  (Fig. 3), and contained no fragments uniquely 
shared with 5E or 79B, CHO has been assigned to the end of 
Frl that contains  104. 
Two  aspects  of the  Frl  epitope  map  therefore remain 
undefined: the relative order of 12B, 9A,  liB, 10A, and 104, 
which,  however, are confined to a  region of <17  kD,  and 
orientation of the map with respect to the amino terminus. 
We initially assigned both the  104 and CHO carbohydrate- 
dependent epitopes to the carboxyl terminus on the basis of 
previous studies that indicate that most, if not all, N-CAM 
carbohydrate is  associated  with  the  central  region  of the 
N-CAM polypeptide chain (3,  14). This placement is sup- 
ported by fragment T23 (Table I), which contains epitopes 
PP,  12A, 9A,  liB, and 10A, but not 104 or CHO. Moreover, 
it  has  recently been  established  that  the  25-kD  heparin- 
binding fragment (1), which contains the 5E and 79B epi- 
topes (27), has the same NH2-terminal amino acid sequence 
as the intact molecule (Cole, G.,  and L.  Glaser, personal 
communication). With the establishment of this orientation, 
the approximate distances of the Frl epitopes from the amino 
terminus of N-CAM are: 5E at 22 kD, 79B at 23 kD, PP at 
40 kD, the 12B to 104 complex within 41-58 kD, and CHO 
near the 59-kD Frl  terminus. 
The central portion of N-CAM, which contains the PSA 
residues and extends to the cell membrane, is represented by 
epitopes CHO,  105, and 20A.  Of these, only 105  is not a 
carbohydrate-dependent antigen,  and as mentioned above, 
CHO is present on at least three different sites and cannot 
be used to identify overlapping peptides between this region 
and Frl. The overall placement of these epitopes is based on 
fragments C36(65-130) and C25(31).  C36(65-130) contains 
PSA (2),  CHO,  and  105, whereas C25(31)  has  105, CHO, 
20A, 30B, and 4D. Because peptide V25 only reacted with 
mAb 105, and fragment V18(21) only contained 20A and 30B, 
it follows that PSA and CHO both must lie near one end of 
C36(65-130) and 105 at the other (see Fig. 5). Similarly, the 
size of  V18(21) argues that 105 is immediately followed by an- 
other CHO epitope. The data would also allow CHO to lie 
in a small intracellular region between 30B and 4D, a possi- 
bility that seems unlikely in view of the carbohydrate nature 
of this epitope. Placement of the 20A epitope near the NH2- 
terminal end of V18(21) and near CHO is based on the fact 
that this mAb reacts with N-CAM-110. 
The cytoplasmic domain of N-CAM-160 has two markers, 
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Figure 5. Mapping of mAb epitopes along the N-CAM polypeptides. Peptide names as defined in Tables I and II are indicated at the margins 
of the figure. Only a minimal subset of the peptides used to construct the map (see text) are illustrated; other peptides listed in the two 
tables serve to confirm the assignments of epitope position. The estimated size of the N-CAM polypeptides and their peptide fragments, 
without carbohydrate, is represented by the length of each line, with the scale in kilodaltons at the top of the figure. Epitopes associated 
with each peptide are shown, with individual positions by vertical lines; several epitopes were located together between 40 and 60 kD, 
and are grouped within parentheses. Carbohydrate-dependent epitopes have been enclosed by boxes. 
30B and 4D. As indicated above, fragments V18(21) places 
105, CHO, and 20A at one end of C25(31) and, consequently, 
30B followed by 4D at the other. The order and close prox- 
imity of 30B and 4D is further supported by the size of T21, 
which contains only 4D and therefore extends toward the car- 
boxyl terminus of N-CAM-160. The orientation of the cen- 
tral and intracellular regions is indicated by the fact that 30B 
and 4D are both located inside the cell (27) and the carboxyl 
termini of N-CAM-140 and N-CAM-160 have been shown 
to extend into the cell cytoplasm (9, 27). 
Although no fragment was found that overlapped Frl and 
the central region, the position of this second group of epi- 
topes could be estimated from the properties of the naturally 
occurring  ll0-kD  N-CAM  polypeptide.  This  form of the 
molecule contains all the epitopes except for 30B and 4D, 
and its size indicates that peptide C36(65-130) must begin 
within ,~10 kD of the end of Frl. With this placement, the 
length of the overlapping fragments described above would 
extend to within •6  kD of  the carboxyl terminus of N-CAM- 
160. The assignment of approximate epitope positions from 
the amino terminus would therefore be PSA and CHO at 
70-80 kD, 105 at 106 kD, CHO again at 108 kD, 20A at 110 
kD, 30B at 130 kD, and 4D at 132 kD. 
Discussion 
In the accompanying report we describe a group of mAbs 
that can discriminate among and perturb the known major 
structural  and  functional regions of N-CAM.  The results 
presented in this paper serve to assign the antigenic epitopes 
recognized by these antibodies to positions along the poly- 
peptide chain.  The purpose of this discussion, after initial 
comments on  the  epitope map,  is  to  combine these  new 
findings with our existing knowledge about N-CAM in the 
form of a topographical model of the molecule in association 
with the cell membrane (Fig. 6). 
mAb epitope mapping on peptide fragments has been used 
to establish overall landmarks for several large proteins (see 
the  introduction).  In  this  approach,  the  establishment  of 
structure-function relationships has usually been based on a 
correlation between the biological effects of different mAbs 
and their ability to compete with each other in binding to the 
native intact protein (see 7,  18). While binding competition 
studies to native N-CAM were included in our characteriza- 
tion of anti-N-CAM mAbs, we have attempted to obtain ad- 
ditional information by preparation of a variety of overlap- 
ping peptides using SDS PAGE for peptide fractionation and 
size determination, and immunoblots to assess similarities 
and differences between the fragments. The major assump- 
tions required in this method are that the antigenic deter- 
minants are still detectable after fragmentation of the pro- 
tein, and that these epitopes are not irreversibly destroyed 
during SDS PAGE. To minimize such difficulties, the mAbs 
were  screened  for  their  ability  to  react  with  proteolytic 
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Figure 6. Schematic represen- 
tation of an isolated N-CAM 
glycopeptide in the cell mem- 
brane. The model summarizes 
both the position  of epitopes 
along the polypeptide and the 
structural-functional  charac- 
terization  of  the  antibodies 
used  to  identify  them.  Also 
illustrated  are  a  variety  of 
chemical  and conformational 
features based on other  stud- 
ies  (see  text).  The different, 
naturally  occurring  forms  of 
N-CAM  are  delineated  by 
dashed  lines;  the  N-CAM- 
160, N-CAM-130, and N-CAM-ll0 polypeptides differ in their carboxyl-terminal  cytoplasmic extensions as illustrated by the lines at or 
near the cell membrane and near epitope 30B; the smaller amount of PSA on embryonic retinal or adult brain N-CAM is indicated by 
the lines through the multiple carbohydrate chains shown extending from the central region of the molecule. Nine PSA chains of equal 
length are depicted,  but the actual distribution  of the sugar among these chains may differ substantially. Also, although the location of 
the heparin-binding region is indicated, it is not known if all forms of N-CAM have this activity. This model is not precise in the folding 
of the polypeptide chain or the exact relative positions of all epitopes, but attempts to account for the overall size, shape, membrane disposi- 
tion,  and functions of the molecule in terms of its known biochemical properties. 
digests of N-CAM that had been boiled in SDS and trans- 
ferred to nitrocellulose.  When sensitive detection methods 
were used in the immunoblots, more than half of all anti-N- 
CAM monoclonal reagents passed this test, and therefore ex- 
tensive epitope mapping was possible. 
Ultimately, the best test of such a method is whether it can 
produce a complete and logically consistent map. Using con- 
ventional methods throughout and a modest number of anti- 
bodies and fragmentation schemes, we have been able to as- 
semble a map placing 14 different antigenic sites, often with 
a high degree of resolution.  Together, the mapped peptides 
account  for essentially the  entire  polypeptide chain,  with 
only a single break in fragment linkage (see below). 
How useful is the model produced by this analysis? The 
most relevant criterion is whether the model can be used to 
map newly discovered sites or activities and relate them to 
existing ones.  In fact,  the binding  activity of N-CAM  for 
heparin was discovered by Cole and Glaser (1) after comple- 
tion of the epitope map,  and could be introduced  into the 
model  through  relatively  simple  tests.  First,  their  mAb 
B1A3,  which  inhibits  heparin-N-CAM  binding,  was  im- 
munoblotted against the set of N-CAM fragments generated 
in this study and found to match exactly those obtained with 
mAbs 5E and 79B. Second, the 25-kD heparin-binding frag- 
ment (1) was tested against the bank of mapped mAbs and 
found only to react with 5E and 79B (27). Thus, we were able 
to provide detailed support for their hypothesis that adhe- 
sion-inhibiting  mAbs  recognize  more than  one  region  of 
N-CAM, including one associated with heparin-binding ac- 
tivity. However, since heparin may not bind to all forms of 
N-CAM, 5E and 79B should as yet be considered as markers 
for the region rather than the activity itself. 
The known or proposed molecular features and biological 
activities of N-CAM are presented schematically in Fig. 6, 
together with the epitopes that serve to locate and perturb 
them. In addition to the present map and earlier less-detailed 
versions of the molecule (see the introduction),  this model 
incorporates  several additional  observations,  as  discussed 
below. 
Although the epitope map did not provide a sequence for 
12B,  9A,  llB,  and  10A, the  spatial  relationships  shown 
among these epitopes attempt to illustrate some of the results 
of the binding competition studies in the accompanying re- 
port. For example, mAb 9A interfered with binding of llB 
and PP,  and PP interfered with 79B as well as 9A and liB. 
In a two-dimensional schematic illustration, however, it was 
not possible to represent all of the competition studies ac- 
curately. In any case, it is notable that the overall results of 
the binding competition studies, which were carried out on 
native, membrane-bound N-CAM, are completely consistent 
with the epitope map. Thus, the  10A to PP group,  and the 
5E  and  79B  group competed more strongly  within them- 
selves than with each other, and there was no interaction with 
105. 
An additional rationale for grouping of epitopes was their 
effect on cell-cell adhesion.  Half of the mAbs tested had 
strong and reproducible effects on adhesion, and these could 
be divided into three categories: those whose Fabs inhibited 
adhesion (PP and 12B),  Fabs that caused a strong enhance- 
ment (9A and llB), and those that inhibited but are located 
in the heparin binding region (5E and 79B). With respect to 
multiple site contribution to cell-cell binding activity, it is 
interesting that combinations of Fabs from the two different 
inhibitory  groups  (for example  12B  and  5E),  were  more 
effective than either alone (27).  Altogether,  it appears that 
both binding activities and all of the rnAbs described here 
that affect adhesion are concentrated in a  single compact, 
highly antigenic domain derived from '~40 kD of contiguous 
polypeptide. 
The existence of mAbs whose monovalent Fab fragments 
enhance adhesion was at first surprising.  However, another 
alteration of N-CAM,  the  removal of PSA,  has also been 
shown to enhance aggregation rates (2, 25).  It is therefore 
possible that the attachment of Fab outside of an actual bind- 
ing site might cause a conformational change that mimics the 
effects on adhesion produced by removal of PSA. 
The fact that the site of cleavage to produce Frl coincides 
with the only portion of the map that did not yield an overlap- 
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general protease sensitivity, as indicated by the extended seg- 
ment between Frl and the central domain in the model. Fur- 
thermore,  based  on electron microscopic observations of 
N-CAM-160 (Hall, A., and U. Rutishauser, unpublished ob- 
servations, also see reference 4),  we propose that this ex- 
tended region is more flexible relative to other regions, and 
therefore could influence cell-cell distance as well as inter- 
and intramolecular interactions. 
The depiction of the central carbohydrate-rich domain is 
highly schematic, as there is relatively little known about the 
number and length of the unbranched alpha-2, 8-1inked sialic 
acid polymers. The illustration of nine chains of ~25 resi- 
dues  each  reflects  the  evidence  that  there  are  three  N- 
linked carbohydrate cores located in the sialic acid-contain- 
ing peptide  (14),  each with the potential for one to three 
chains (6), and that the heavily sialylated form of the mole- 
cule from embryonic brain is 30% sialic acid by weight (15) 
or '~225 sialic acid residues. In the absence of  data to suggest 
whether all possible chains exist or if there are differences 
in their length, the total amount of sialic acid has been shown 
in  a  uniform distribution.  In contrast,  N-CAM  from em- 
bryonic retina or postnatal brain has only one-third of this 
amount of sialic acid (15, 21) (see dashed line in Fig. 6), and 
the distribution of the saccharide does not appear to be uni- 
form (6). 
The next feature depicted in the model is the membrane- 
associated region. The position of the membrane is defined 
by the inter- and intracellular location of epitopes described 
in the accompanying paper, the carboxyl terminus of N-CAM- 
110 that has been proposed to not have a significant intracel- 
lular component (dashed line at the membrane in Fig. 6) (9, 
13), and  the  size  of the  largest  (108-kD)  fragment,  Fr2, 
released from intact cells by limited proteolysis (3). This re- 
gion is most accurately marked by epitope 20A and is also 
near 105 and the most carboxyl-terminal CHO determinant. 
It has been depicted tentatively as an extended region on the 
basis of both its sensitivity to proteolysis in the production 
of Fr2 (3), and the fact that transmembrane segments of pro- 
teins are often composed of a single alpha helix. An impor- 
tant assumption in the model is that the polypeptide chain 
traverses the cell membrane only once, or at least within 
a short stretch of polypeptide. In support of this feature is 
the fact that all epitopes mapped in the amino-terminal ll0- 
kD portion of N-CAM are extracellular and/or carbohydrate- 
dependent, and both determinants in the remainder of the 
polypeptide are intracellular (27). Also, the large size of pep- 
tides  protected from extracellular proteolysis suggest that 
there is not a large extracellular component in the carboxyl- 
terminal  region  (9).  The  most  direct evidence,  however, 
comes from the recent gene sequence analysis (13), which in- 
dicates  that  there  is  a  single  hydrophobic  region  in  the 
COOH-terminal half of N-CAM, precisely at the site sug- 
gested by our studies. 
The  intracellular  domains  are  the  least  well-described 
parts of N-CAM. The different polypeptide forms (160, 130, 
and 110 kD) are depicted as having a 50-kD, a 20-kD, and 
no cytoplasmic extension, respectively (see dashed lines in 
Fig. 6). Although it has been suggested that these N-CAMs 
are derived from a single gene (12, 19) produced from differ- 
ent messenger RNAs,  nothing is known about the function 
of this portion of the polypeptide. However, one or more 
phosphorylation sites, at threonine and serine residues, have 
been reported to occur in each of the two intraceUular do- 
mains (10,26). An extended segment at 130 kD in N-CAM- 
160 is illustrated primarily to allow for the fact that the cyto- 
plasmic portion of N-CAM-130 can exist and presumably 
function by itself and is therefore likely to represent a domain 
that folds independently of the 130-160-kD region. It is nota- 
ble that the proposed extended segment also contains both 
the antigenic sites recognized by 30B and 4D. 
In summary, the incorporation into an epitope map of in- 
formation obtained in studies from several laboratories has 
led  to  the  formulation of a  more  detailed  topographical 
model for N-CAM. Although the model will need consider- 
able refinement, it should serve as a basis for testing a variety 
of structure-function relationships, particularly through the 
use of the mAbs that mark and perturb its key features. 
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